VR Logo

Brickell Biotech Inc. (BBI) download report


Healthcare | Biotechnology & Pharma Research

Brickell Biotech Inc. (BBI) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States.

IPO Date: 15-Mar-1993

Co-Founder & Chairman: Mr. Reginald L. Hardy M.B.A., R.Ph.

CEO & Director: Attorney Robert Busard Brown

Listing: NASDAQ: BBI

Country: United States

Headquarters: Boulder, CO

Website: https://www.brickellbio.com

Key Facts

Market cap: $9.89 Mln

Revenue (TTM): $0.35 Mln

Earnings (TTM): $-39.88 Mln

Cash: $17.29 Mln

Total Debt: $0.05 Mln

Insider's Holding: 1.31%

Liquidity: Low

52 Week range: $2.88 - 303.75

Shares outstanding: 2,653,690

10 Years Aggregate:

  • CFO: $-187.72 Mln
  • EBITDA: $-191.24 Mln
  • Net Profit: $-202.32 Mln

Stock Performance

Time Period Brickell Biotech (BBI) S&P BSE Sensex S&P Small-Cap 600
YTD-68.791.85-9.40
1 month-15.898.9011.02
3 months-66.499.148.82
1 Year-88.968.76-6.43
3 Years-76.6416.4410.91
5 Years-66.4713.488.84
10 Years-55.6212.9510.89
As on 11-Aug-2022
Year Brickell Biotech (BBI) S&P Small-Cap 600 S&P BSE Sensex
2021-70.5325.2721.99
2020-47.979.5715.75
2019-81.8420.8614.38
2018-35.36-9.705.87
2017-20.4311.7327.91
2016-43.9024.741.95
2015-60.95-3.36-5.03